Christopher Swearingen, Ph.D.

Vice President, Biometrics

Professional Overview
Christopher Swearingen, Ph.D., is an accomplished biostatistics and biometrics expert with extensive experience in the pharmaceutical and healthcare industries. As the Vice President of Biometrics at Biosplice Therapeutics, he leverages his deep expertise in clinical outcomes analysis, data management, and statistical modeling to drive the development of innovative therapeutic solutions.

Experience Summary

Current Role
As the Vice President of Biometrics at Biosplice Therapeutics, Dr. Swearingen oversees all aspects of biostatistics, data management, and clinical outcomes assessment for the company's pipeline of novel regenerative medicine therapies. He leads a team of highly skilled biostatisticians and data analysts, ensuring the integrity and reliability of clinical data to support regulatory submissions and strategic decision-making. Under his leadership, Biosplice has achieved significant milestones in the advancement of its therapeutic candidates, with several programs progressing through late-stage clinical trials.

Career Progression
Prior to joining Biosplice, Dr. Swearingen served as the Vice President of Clinical Outcomes and Analytics at Samumed, LLC, where he was instrumental in the development and implementation of advanced statistical methodologies to evaluate the efficacy and safety of the company's osteoarthritis and regenerative medicine products. Before that, he held various academic and research positions at the University of Arkansas for Medical Sciences, contributing to the institution's efforts in pediatric genetics and biostatistics.

Academic Background
Dr. Swearingen holds a Ph.D. in Biostatistics from the Medical University of South Carolina, where he conducted groundbreaking research in the application of advanced statistical techniques to the analysis of complex genetic and clinical data. He also possesses a strong background in pediatrics and genetics, having served as an Assistant Professor in these fields at the University of Arkansas for Medical Sciences.

Areas of Expertise

• Biostatistics and data analysis

• Clinical outcomes assessment

• Biometrics and data management

• Regulatory submissions and support

• Regenerative medicine and orthopedics

• Team leadership and collaboration

Professional Impact
Throughout his career, Dr. Swearingen has made significant contributions to the advancement of biometrics and clinical research in the pharmaceutical industry. He has authored numerous peer-reviewed publications and has been recognized as a subject matter expert, serving on the NIDDK O'Brien Center Review Panel at the National Institutes of Health. Under his leadership, the biometrics teams he has overseen have consistently delivered high-quality data and analyses that have supported the successful advancement of novel therapeutic candidates.

Conclusion
With his extensive expertise in biostatistics, biometrics, and clinical research, Dr. Christopher Swearingen is a valuable asset to Biosplice Therapeutics and the broader pharmaceutical industry. His proven ability to translate complex data into actionable insights, coupled with his strong leadership and collaboration skills, position him as a key contributor to the development of transformative regenerative medicine therapies.